Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07489196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-101 in treating patients with β-Thalassemia Major
Trial Details
NCT Number NCT07489196
Lead Sponsor CorrectSequence Therapeutics Co., Ltd
Conditions
(from sponsor)		 β-thalassemia Major
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov